Introducing human APOE into Aβ transgenic mouse models

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Tai, Leon M ^a   Youmans, Katherine L ^a   Jungbauer, Lisa ^a,b   Yu, Chunjiang ^a   LaDu, Mary Jo ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; AMYLOID PLAQUE; APOE GENE; DISEASE COURSE; DISEASE MODEL; GENE; HEAD INJURY; HUMAN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

EID: 84855263811     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/810981     Document Type: Review

References (90)

1. Hardy J., The amyloid hypothesis for Alzheimer's disease: a critical reappraisal Journal of Neurochemistry 2009 110 4 1129 1134
2. Wisniewski T., Sigurdsson E. M., Murine models of Alzheimer's disease and their use in developing immunotherapies Biochimica et Biophysica Acta 2010 1802 10 847 859
3. Takeda M., Martnez R., Kudo T., Tanaka T., Okochi M., Tagami S., Morihara T., Hashimoto R., Cacabelos R., Apolipoprotein e and central nervous system disorders: reviews of clinical findings Psychiatry and Clinical Neurosciences 2010 64 6 592 607
4. Verghese P. B., Castellano J. M., Holtzman D. M., Apolipoprotein E in Alzheimer's disease and other neurological disorders The Lancet Neurology 2011 10 3 241 252
5. Bu G., Apolipoprotein e and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Nature Reviews Neuroscience 2009 10 5 333 344
6. Hardy J., Alzheimer's disease: the amyloid cascade hypothesisan update and reappraisal Journal of Alzheimer's Disease 2006 9 3, supplement 151 153 (Pubitemid 44253307)
7. Adlard P. A., Vickers J. C., Morphologically distinct plaque types differentially affect dendritic structure and organisation in the early and late states of Alzheimer's disease Acta Neuropathologica 2002 103 4 377 383 (Pubitemid 36097033)
8. van Groen T., Liu L., Ikonen S., Kadish I., Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions Neuroscience 2003 119 4 1185 1197 (Pubitemid 36776463)
9. Thal D. R., Capetillo-Zarate E., Del Tredici K., Braak H., The development of amyloid beta protein deposits in the aged brain Science of Aging Knowledge Environment 2006 2006 6 re1
10. Fiala J. C., Mechanisms of amyloid plaque pathogenesis Acta Neuropathologica 2007 114 6 551 571 (Pubitemid 50003186)
11. Thal D. R., Griffin W. S. T., Braak H., Parenchymal and vascular A -deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease Journal of Cellular and Molecular Medicine 2008 12 5 1848 1862
12. Dickson T. C., Vickers J. C., The morphological phenotype of -amyloid plaques and associated neuritic changes in Alzheimer's disease Neuroscience 2001 105 1 99 107 (Pubitemid 32722097)
13. Xu Q., Bernardo A., Walker D., Kanegawa T., Mahley R. W., Huang Y., Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus Journal of Neuroscience 2006 26 19 4985 4994 (Pubitemid 44315280)
14. Kim J., Basak J. M., Holtzman D. M., The role of apolipoprotein E in Alzheimer's disease Neuron 2009 63 3 287 303
15. Raber J., Wong D., Buttini M., Orth M., Bellosta S., Pitas R. E., Mahley R. W., Mucke L., Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females Proceedings of the National Academy of Sciences of the United States of America 1998 95 18 10914 10919 (Pubitemid 28413168)
16. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D. M., Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice Neuroscience Letters 1995 199 1 1 4
17. Ji Y., Gong Y., Gan W., Beach T., Holtzman D. M., Wisniewski T., Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients Neuroscience 2003 122 2 305 315 (Pubitemid 37410162)
18. Klein R. C., Mace B. E., Moore S. D., Sullivan P. M., Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2 Neuroscience 2010 171 4 1265 1272
19. Piedrahita J. A., Zhang S. H., Hagaman J. R., Oliver P. M., Maeda N., Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells Proceedings of the National Academy of Sciences of the United States of America 1992 89 10 4471 4475
20. Veinbergs I., Mante M., Jung M. W., Van Uden E., Masliah E., Synaptotagmin and synaptic transmission alterations in apolipoprotein E- deficient mice Progress in Neuro-Psychopharmacology and Biological Psychiatry 1999 23 3 519 531 (Pubitemid 29274221)
21. Robertson J., Curley J., Kaye J., Quinn J., Pfankuch T., Raber J., apoE isoforms and measures of anxiety in probable AD patients and apoE-/-mice Neurobiology of Aging 2005 26 5 637 643 (Pubitemid 40228755)
22. Sun Y., Wu S., Bu G., Onifade M. K., Patel S. N., LaDu M. J., Fagan A. M., Holtzman D. M., Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte- secreted apoE3 and apoE4 lipoproteins Journal of Neuroscience 1998 18 9 3261 3272 (Pubitemid 28186019)
23. Hartman R. E., Wozniak D. F., Nardi A., Olney J. W., Sartorius L., Holtzman D. M., Behavioral phenotyping of GFAP-ApoE3 and -ApoE4 transgenic mice: ApoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology Experimental Neurology 2001 170 2 326 344 (Pubitemid 32758686)
24. van Meer P., Acevedo S., Raber J., Impairments in spatial memory retention of GFAP-apoE4 female mice Behavioural Brain Research 2007 176 2 372 375 (Pubitemid 44880100)
25. Buttini M., Orth M., Bellosta S., Akeefe H., Pitas R. E., Wyss-Coray T., Mucke L., Mahley R. W., Expression of human apolipoprotein E3 or E4 in the brains of apoE-/-mice: isoform-specific effects on neurodegeneration Journal of Neuroscience 1999 19 12 4867 4880 (Pubitemid 29270123)
26. Buttini M., Yu G. Q., Shockley K., Huang Y., Jones B., Masliah E., Mallory M., Yeo T., Longo F. M., Mucke L., Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid peptides but not on plaque formation Journal of Neuroscience 2002 22 24 10539 10548 (Pubitemid 36005128)
27. Harris F. M., Brecht W. J., Xu Q., Mahley R. W., Huang Y., Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase. Modulation by zinc The Journal of Biological Chemistry 2004 279 43 44795 44801 (Pubitemid 39430890)
28. Sullivan P. M., Han B., Liu F., Mace B. E., Ervin J. F., Wu S., Koger D., Paul S., Bales K. R., Reduced levels of human apoE4 protein in an animal model of cognitive impairment Neurobiology of Aging 2011 32 5 791 801
29. Sullivan P. M., Mace B. E., Estrada J. C., Schmechel D. E., Alberts M. J., Human Apolipoprotein E4 Targeted Replacement Mice Show Increased Prevalence of Intracerebral Hemorrhage Associated with Vascular Amyloid Deposition Journal of Stroke and Cerebrovascular Diseases 2008 17 5 303 311
30. Bales K. R., Liu F., Wu S., Lin S., Koger D., DeLong C., Hansen J. C., Sullivan P. M., Paul S. M., Human APOE isoform-dependent effects on brain -amyloid levels in PDAPP transgenic mice Journal of Neuroscience 2009 29 21 6771 6779
31. Bour A., Grootendorst J., Vogel E., Kelche C., Dodart J. C., Bales K., Moreau P. H., Sullivan P. M., Mathis C., Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks Behavioural Brain Research 2008 193 2 174 182
32. Grootendorst J., Bour A., Vogel E., Kelche C., Sullivan P. M., Dodart J. C., Bales K., Mathis C., Human apoE targeted replacement mouse lines: H-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior Behavioural Brain Research 2005 159 1 1 14 (Pubitemid 40410579)
33. Dumanis S. B., Tesoriero J. A., Babus L. W., Nguyen M. T., Trotter J. H., Ladu M. J., Weeber E. J., Turner R. S., Xu B., Rebeck G. W., Hoe H. S., ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo Journal of Neuroscience 2009 29 48 15317 15322
34. Trommer B. L., Shah C., Yun S. H., Gamkrelidze G., Pasternak E. S., Ye G. L., Sotak M., Sullivan P. M., Pasternak J. F., LaDu M. J., ApoE isoform affects LTP in human targeted replacement mice NeuroReport 2004 15 17 2655 2658 (Pubitemid 40053957)
35. Siegel J. A., Haley G. E., Raber J., Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice. Neurobiology of Aging. In press
36. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagoplan S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., Alzheimer-type neuropathology in transgenic mice overexpressing V717F -amyloid precursor protein Nature 1995 373 6514 523 527
37. Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., Khan K., Gordon M., Tan H., Games D., Lieberburg I., Schenk D., Seubert P., Mcconlogue L., Amyloid precursor protein processing and A 42 deposition in a transgenic mouse model of Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1997 94 4 1550 1555
38. Irizarry M. C., Soriano F., McNamara M., Page K. J., Schenk D., Games D., Hyman B. T., A deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse Journal of Neuroscience 1997 17 18 7053 7059 (Pubitemid 27427884)
39. Dodart J. C., Mathis C., Saura J., Bales K. R., Paul S. M., Ungerer A., Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice Neurobiology of Disease 2000 7 2 71 85 (Pubitemid 30241204)
40. Bales K. R., Verina T., Cummins D. J., Du Y., Dodel R. C., Saura J., Fishman C. E., Delong C. A., Piccardo P., Petegnief V., Ghetti B., Paul S. M., Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 1999 96 26 15233 15238 (Pubitemid 30019795)
41. Fagan A. M., Watson M., Parsadanian M., Bales K. R., Paul S. M., Holtzman D. M., Human and murine apoE markedly alters A metabolism before and after plaque formation in a mouse model of Alzheimer's Disease Neurobiology of Disease 2002 9 3 305 318 (Pubitemid 34442079)
42. Holtzman D. M., Bales K. R., Tenkova T., Fagan A. M., Parsadanian M., Sartorius L. J., Mackey B., Olney J., McKeel D., Wozniak D., Paul S. M., Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2000 97 6 2892 2897 (Pubitemid 30159268)
43. Bales K. R., Liu F., Wu S., Lin S., Koger D., DeLong C., Hansen J. C., Sullivan P. M., Paul S. M., Human APOE isoform-dependent effects on brain -amyloid levels in PDAPP transgenic mice Journal of Neuroscience 2009 29 21 6771 6779
44. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G., Correlative memory deficits, A elevation, and amyloid plaques in transgenic mice Science 1996 274 5284 99 102 (Pubitemid 26332733)
45. Irizarry M. C., McNamara M., Fedorchak K., Hsiao K., Hyman B. T., APP(Sw) transgenic mice develop age-related A deposits and neuropil abnormalities, but no neuronal loss in CA1 Journal of Neuropathology and Experimental Neurology 1997 56 9 965 973 (Pubitemid 27386126)
46. Takahashi R. H., Milner T. A., Li F., Nam E. E., Edgar M. A., Yamaguchi H., Beal M. F., Xu H., Greengard P., Gouras G. K., Intraneuronal Alzheimer A 42 accumulates in multivesicular bodies and is associated with synaptic pathology American Journal of Pathology 2002 161 5 1869 1879 (Pubitemid 35265544)
47. Fryer J. D., Simmons K., Parsadanian M., Bales K. R., Paul S. M., Sullivan P. M., Holtzman D. M., Human apolipoprotein E4 alters the amyloid- 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model Journal of Neuroscience 2005 25 11 2803 2810 (Pubitemid 40389238)
48. Hsia A. Y., Masliah E., Mcconlogue L., Yu G. Q., Tatsuno G., Hu K., Kholodenko D., Malenka R. C., Nicoll R. A., Mucke L., Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 3228 3233 (Pubitemid 29148873)
49. Oakley H., Cole S. L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., Vassar R., Intraneuronal -amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation Journal of Neuroscience 2006 26 40 10129 10140 (Pubitemid 44527407)
50. Youmans K., Laxton K., Jungbauer L. M., Yu C., LaDu M., The Effects of Human ApoE on Amyloid-beta Pathology in a Novel Transgenic Mouse Model 2010 San Diego, Calif, USA Society for Neuroscience
51. Youmans K., Tai L., Laxton K., ApoE isoform-specific effects on A pathology in EFAD mice Proceedings of the 2nd annual symposium of ApoE, ApoE Receptors, and Neurodegeneration 2011 Chicago, Ill, USA
52. Youmans K. L., The effects of human apoE on amyloid-beta (42) pathology and synaptic loss in a novel transgenic mouse model Proceedings of the American Society for Neurochemistry Meeting 2010 Santa Fe, NM, USA Transactions of the American Society for Neurochemistry
53. Yu C., Youmans K. L., Jungbauer L. M., Selective increases in soluble ApoE4 and A 42 in EFAD mouse brains Proceedings of the ApoE, ApoE Receptors and Neurodegeneration 2011 Chicago, Ill, USA
54. Hatters D. M., Peters-Libeu C. A., Weisgraber K. H., Apolipoprotein E structure: insights into function Trends in Biochemical Sciences 2006 31 8 445 454 (Pubitemid 44108662)
55. Tesseur I., Van Dorpe J., Bruynseels K., Bronfman F., Sciot R., Van Lommel A., Van Leuven F., Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord American Journal of Pathology 2000 157 5 1495 1510
56. Smith J. D., Sikes J., Levin J. A., Human apolipoprotein E allele-specific brain expressing transgenic mice Neurobiology of Aging 1998 19 5 407 413 (Pubitemid 29065490)
57. Huber G., Mrz W., Martin J. R., Malherbe P., Richards J. G., Sueoka N., Ohm T., Hoffmann M. M., Characterization of transgenic mice expressing Apolipoprotein E4(C112R) and Apolipoprotein E4(L28P; C112R) Neuroscience 2000 101 1 211 218
58. Bowman B. H., Jansen L., Yang F., Adrian G. S., Zhao M., Atherton S. S., Buchanan J. M., Greene R., Walter C., Herbert D. C., Weaker F. J., Chiodo L. K., Kagan-Hallet K., Hixson J. E., Discovery of a brain promoter from the human transferrin gene and its utilization for development of transgenic mice that express human apolipoprotein E alleles Proceedings of the National Academy of Sciences of the United States of America 1995 92 26 12115 12119 (Pubitemid 26014022)
59. Tesseur I., Van Dorpe J., Spittaels K., Van den Haute C., Moechars D., Van Leuven F., Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice American Journal of Pathology 2000 156 3 951 964 (Pubitemid 30626953)
60. Han S. H., Einstein G., Weisgraber K. H., Strittmatter W. J., Saunders A. M., Pericak-Vance M., Roses A. D., Schmechel D. E., Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study Journal of Neuropathology and Experimental Neurology 1994 53 5 535 544 (Pubitemid 24276812)
61. Han S. H., Hulette C., Saunders A. M., Einstein G., Pericak-Vance M., Strittmatter W. J., Roses A. D., Schmechel D. E., Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls Experimental Neurology 1994 128 1 13 26 (Pubitemid 24278361)
62. Buttini M., Masliah E., Yu G. Q., Palop J. J., Chang S., Bernardo A., Lin C., Wyss-Coray T., Huang Y., Mucke L., Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice American Journal of Pathology 2010 177 2 563 569
63. Chen H. K., Ji Z. S., Dodson S. E., Miranda R. D., Rosenblum C. I., Reynolds I. J., Freedman S. B., Weisgraber K. H., Huang Y., Mahley R. W., Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for alzheimer disease The Journal of Biological Chemistry 2011 286 7 5215 5221
64. Mufson E. J., Benzing W. C., Cole G. M., Wang H., Emerich D. F., Sladek J. R. Jr., Morrison J. H., Kordower J. H., Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: colocalization with amyloid plaques Neurobiology of Aging 1994 15 5 621 628 (Pubitemid 24287334)
65. Fujita S. C., Sakuta K., Tsuchiya R., Hamanaka H., Apolipoprotein E is found in astrocytes but not in microglia in the normal mouse brain Neuroscience Research 1999 35 2 123 133 (Pubitemid 29518403)
66. Stone D. J., Rozovsky I., Morgan T. E., Anderson C. P., Hajian H., Finch C. E., Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro Experimental Neurology 1997 143 2 313 318 (Pubitemid 27148235)
67. Grehan S., Tse E., Taylor J. M., Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain Journal of Neuroscience 2001 21 3 812 822 (Pubitemid 32163122)
68. Poirier J., Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease Neurobiology of Aging 2005 26 3 355 361 (Pubitemid 40082719)
69. Poirier J., Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease Alzheimer's and Dementia 2008 4 1, supplement S91 S97
70. Ramaswamy G., Xu Q., Huang Y., Weisgraber K. H., Effect of domain interaction on apolipoprotein E levels in mouse brain Journal of Neuroscience 2005 25 46 10658 10663 (Pubitemid 41681913)
71. Raffa R. L., Dong L. M., Farese R. V., Weisgraber K. H., Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E Proceedings of the National Academy of Sciences of the United States of America 2001 98 20 11587 11591 (Pubitemid 32928772)
72. Bertrand P., Poirier J., Oda T., Finch C. E., Pasinetti G. M., Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease Molecular Brain Research 1995 33 1 174 178
73. Glckner F., Meske V., Ohm T. G., Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease Neuroscience 2002 114 4 1103 1114
74. Sun Y., Wu S., Bu G., Onifade M. K., Patel S. N., LaDu M. J., Fagan A. M., Holtzman D. M., Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte- secreted apoE3 and apoE4 lipoproteins Journal of Neuroscience 1998 18 9 3261 3272 (Pubitemid 28186019)
75. Tang K. F., Cai L., Zhou J. N., Observation of the density and size of cells in hippocampus and vascular lesion in thalamus of GFAP-apoE transgenic mice Neuroscience Bulletin 2009 25 4 167 178
76. Wirths O., Bayer T. A., Neuron loss in transgenic mouse models of Alzheimer's disease International Journal of Alzheimer's Disease 2010 2010 6
77. Dodart J. C., Bales K. R., Johnstone E. M., Little S. P., Paul S. M., Apolipoprotein E alters the processing of the -amyloid precursor protein in APPV717F transgenic mice Brain Research 2002 955 1-2 191 199 (Pubitemid 35284849)
78. Bales K. R., Verina T., Cummins D. J., Du Y., Dodel R. C., Saura J., Fishman C. E., Delong C. A., Piccardo P., Petegnief V., Ghetti B., Paul S. M., Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 1999 96 26 15233 15238 (Pubitemid 30019795)
79. Bales K. R., Verina T., Dodel R. C., Du Y., Altstiel L., Bender M., Hyslop P., Johnstone E. M., Little S. P., Cummins D. J., Piccardo P., Ghetti B., Paul S. M., Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition Nature genetics 1997 17 3 263 264
80. Holtzman D. M., Fagan A. M., Mackey B., Tenkova T., Sartorius L., Paul S. M., Bales K., Ashe K. H., Irizarry M. C., Hyman B. T., Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model Annals of Neurology 2000 47 6 739 747 (Pubitemid 30390194)
81. Raber J., Wong D., Yu G. Q., Buttini M., Mahley R. W., Pitas R. E., Mucke L., Apolipoprotein E and cognitive performance Nature 2000 404 6776 352 354 (Pubitemid 30164327)
82. Hartman R. E., Laurer H., Longhi L., Bales K. R., Paul S. M., McIntosh T. K., Holtzman D. M., Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease Journal of Neuroscience 2002 22 23 10083 10087 (Pubitemid 35416846)
83. Colton C. A., Wilcock D. M., Wink D. A., Davis J., Van Nostrand W. E., Vitek M. P., The effects of NOS2 gene deletion on mice expressing mutated human A PP Journal of Alzheimer's Disease 2008 15 4 571 587
84. Belinson H., Lev D., Masliah E., Michaelson D. M., Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits Journal of Neuroscience 2008 28 18 4690 4701
85. Dolev I., Michaelson D. M., A nontransgenic mouse model shows inducible amyloid- (A ) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade Proceedings of the National Academy of Sciences of the United States of America 2004 101 38 13909 13914 (Pubitemid 39298506)
86. Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., Kayed R., Metherate R., Mattson M. P., Akbari Y., LaFerla F. M., Triple-transgenic model of Alzheimer's Disease with plaques and tangles: intracellular A and synaptic dysfunction Neuron 2003 39 3 409 421 (Pubitemid 36937044)
87. Oddo S., Caccamo A., Smith I. F., Green K. N., LaFerla F. M., A dynamic relationship between intracellular and extracellular pools of A American Journal of Pathology 2006 168 1 184 194 (Pubitemid 43062572)
88. Casas C., Sergeant N., Itier J. M., Blanchard V., Wirths O., Van Der Kolk N., Vingtdeux V., Van De Steeg E., Ret G., Canton T., Drobecq H., Clark A., Bonici B., Delacourte A., Benavides J., Schmitz C., Tremp G., Bayer T. A., Benoit P., Pradier L., Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated A 42 accumulation in a novel Alzheimer transgenic model American Journal of Pathology 2004 165 4 1289 1300 (Pubitemid 39297734)
89. Radde R., Bolmont T., Kaeser S. A., Coomaraswamy J., Lindau D., Stoltze L., Calhoun M. E., Jggi F., Wolburg H., Gengler S., Haass C., Ghetti B., Czech C., Hlscher C., Mathews P. M., Jucker M., A 42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology EMBO Reports 2006 7 9 940 946 (Pubitemid 44523975)
90. Chishti M. A., Yang D. S., Janus C., Phinney A. L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P. E., Carlson G. A., George -. P. S., Westawaya D., Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 The Journal of Biological Chemistry 2001 276 24 21562 21570 (Pubitemid 37413154)